Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Doxylamine/Pyridoxine Formulations in Healthy Women
NCT03905564Phase 1Withdrawn
- Sponsor
- Grünenthal GmbH
- Start
- Jun 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of doxylamine and pyridoxine in nausea and vomiting of pregnancy (NVP) (2 arms), sponsored by Grünenthal GmbH. Primary endpoints: Area under the plasma concentration curve from administration to time t and Maximum plasma concentration. Planned start Jun 2019; status: withdrawn.
02
Drugs
doxylaminepyridoxine
03
Conditions
nausea and vomiting of pregnancy (NVP)
Beyond the preview
Go deeper on NCT03905564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03905564.